Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP176681.RA8xo_cexnDgxDlt4tFp-ThsnsFK_BpGj6k9-Rln337ws130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP176681.RA8xo_cexnDgxDlt4tFp-ThsnsFK_BpGj6k9-Rln337ws130_assertion type Assertion NP176681.RA8xo_cexnDgxDlt4tFp-ThsnsFK_BpGj6k9-Rln337ws130_head.
- NP176681.RA8xo_cexnDgxDlt4tFp-ThsnsFK_BpGj6k9-Rln337ws130_assertion description "[Strong HER3 staining was found in 26.7% of both the primary tumors and the corresponding metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP176681.RA8xo_cexnDgxDlt4tFp-ThsnsFK_BpGj6k9-Rln337ws130_provenance.
- NP176681.RA8xo_cexnDgxDlt4tFp-ThsnsFK_BpGj6k9-Rln337ws130_assertion evidence source_evidence_literature NP176681.RA8xo_cexnDgxDlt4tFp-ThsnsFK_BpGj6k9-Rln337ws130_provenance.
- NP176681.RA8xo_cexnDgxDlt4tFp-ThsnsFK_BpGj6k9-Rln337ws130_assertion SIO_000772 18172732 NP176681.RA8xo_cexnDgxDlt4tFp-ThsnsFK_BpGj6k9-Rln337ws130_provenance.
- NP176681.RA8xo_cexnDgxDlt4tFp-ThsnsFK_BpGj6k9-Rln337ws130_assertion wasDerivedFrom lhgdn-20090331 NP176681.RA8xo_cexnDgxDlt4tFp-ThsnsFK_BpGj6k9-Rln337ws130_provenance.
- NP176681.RA8xo_cexnDgxDlt4tFp-ThsnsFK_BpGj6k9-Rln337ws130_assertion wasGeneratedBy ECO_0000203 NP176681.RA8xo_cexnDgxDlt4tFp-ThsnsFK_BpGj6k9-Rln337ws130_provenance.